Life Scientist > Biotechnology

Genetic manipulation to free Murray-Darling of carp

02 May, 2002 by Melissa Trudinger

CSIRO scientists have hatched an ambitious plan to wipe out carp in the Murray-Darling River, by using genetically manipulated carp that lack the ability to change sex.


BresaGen to build new research facility

02 May, 2002 by Daniella Goldberg

Adelaide-based company BresaGen has received $8.9 million from the South Australian government to build a new research facility at the Thebarton Biotechnology Precinct.


Transgenic start-up stalled by grant freeze

02 May, 2002 by Tanya Hollis

A Melbourne start-up looking at pigs as potential organ donors is among hundreds of Australian businesses to be affected by the suspension of the Federal government's R&D Start program.


Peacock to head Academy of Science

01 May, 2002 by Daniella Goldberg

CSIRO Plant Industry chief Dr Jim Peacock has been elected to head the Australian Academy of Science (AAS) after 27 years in the academy.


Analytica achieves its first positive cash flow

01 May, 2002 by Tanya Hollis

Analytica has posted its first positive operating cash flow on the back of its takeover by listed medical diagnostics group Psiron last year.


Looking sharp in two hats

30 April, 2002 by Pete Young

Scientist-turned-financier Dr Kevin Healey is one of an elite group which has used its life science credentials as a springboard to make a splash as venture capitalists.


Prima technology showing positive results

30 April, 2002 by Tanya Hollis

Prima Biomed's (ASX: PRR) vaccine platform technology has taken another step towards success by triggering a strong immune response in large animals, the company reported today.


Wilmut disappointed, others happy with cloning progress

30 April, 2002 by Melissa Trudinger

Recent media interviews with Dr Ian Wilmut, the scientist responsible for cloning Dolly the sheep, have suggested that all clones are genetically and physically defective.


McGauran promises action on killer jellyfish research

30 April, 2002 by Iain Scott

Science Minister Peter McGauran has pledged his support to a call for funding to research the tiny irukandji jellyfish, which has claimed two lives off the Queensland coast this year.


New bio-investor launches IPO

29 April, 2002 by Tanya Hollis

Australia's latest biotech share offering opens this week when device and diagnostics investment company Premier Bionics launches its IPO.


ES Cell scores US grant, license deal

29 April, 2002 by Tanya Hollis

Melbourne's ES Cell International has scored a double coup in the United States with the awarding of a National Institutes of Health infrastructure grant and the signing of a research licensing deal.


BresaGen wins NIH deal

26 April, 2002 by Tanya Hollis

A second Australian company has won the right to provide embryonic stem cell lines to the National Institutes of Health (NIH) in the United States.


Dwarf grapes may revolutionise viticulture

26 April, 2002 by Melissa Trudinger

Australian scientists have discovered a mutation in grapevines equivalent to the dwarfing mutation in cereals discovered in the 1960s that was the basis of the "green revolution", which saw an increase in wheat yields.


GE-free zones inhibit farmers' freedom: Avcare

24 April, 2002 by Daniella Goldberg

Farmers need to be given freedom to grow their choice of crops - GM, organic or conventional - and this freedom is inhibited by GE-free zones being imposed by certain councils and local governments, according to Avcare.


Ellex teams with US on laser deal

24 April, 2002 by Iain Scott

A new deal with US firm Lumenis will allow South Australian company Ellex Medical Lasers to design, develop and manufacture a range of lasers to treat secondary cataracts and glaucoma.


  • All content Copyright © 2024 Westwick-Farrow Pty Ltd